{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:31:13Z","timestamp":1772004673603,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.nmd.2020.09.029","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:19:49Z","timestamp":1600863589000},"page":"925-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myotonic dystrophy and recurrent pleomorphic adenomas: Case report and association hypothesis"],"prefix":"10.1016","volume":"30","author":[{"given":"Ineke M.J.","family":"Pruijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M.L.","family":"van Herpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoert A.H.","family":"Pegge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana C.H.","family":"van Engen van Grunsven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolijn J.","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.A.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nmd.2020.09.029_bib0001","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000118206.49652.A3","article-title":"Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1","volume":"62","author":"Logigian","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0002","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bbadis.2014.01.004","article-title":"Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2","volume":"1842","author":"Carpentier","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.nmd.2020.09.029_bib0003","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/nar\/gkt1020","article-title":"Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron","volume":"42","author":"Echeverria","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.nmd.2020.09.029_bib0004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/j.2040-4603.2018.tb00015.x","article-title":"Myotonic Dystrophy and Developmental Regulation of RNA Processing","volume":"8","author":"Thomas","year":"2018","journal-title":"Compr Physiol"},{"issue":"10","key":"10.1016\/j.nmd.2020.09.029_bib0005","first-page":"2009","article-title":"Hypothesis: neoplasms in myotonic dystrophy","volume":"20","author":"Mueller","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"22","key":"10.1016\/j.nmd.2020.09.029_bib0006","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1001\/jama.2011.1796","article-title":"Cancer risk among patients with myotonic muscular dystrophy","volume":"306","author":"Gadalla","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0007","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mus.25145","article-title":"A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy","volume":"54","author":"Abbott","year":"2016","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mus.26194","article-title":"Cancer phenotype in myotonic dystrophy patients: results from a meta-analysis","volume":"58","author":"Emparanza","year":"2018","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2020.09.029_bib0009","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acn3.50856","article-title":"Benign tumors in myotonic dystrophy type I target disease-related cancer sites","volume":"6","author":"Alsaggaf","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2020.09.029_bib0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/014556130608500201","article-title":"World Health Organization classification of tumours: pathology and genetics of head and neck tumours","volume":"85","author":"Thompson","year":"2006","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"10.1016\/j.nmd.2020.09.029_bib0011","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hed.20613","article-title":"Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients","volume":"29","author":"Wittekindt","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.nmd.2020.09.029_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.oraloncology.2017.01.004","article-title":"Salivary gland pleomorphic adenoma in the Netherlands: a nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence","volume":"66","author":"Valstar","year":"2017","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.nmd.2020.09.029_bib0013","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcms.2007.02.003","article-title":"Long-term recurrence rate of pleomorphic adenoma and postoperative facial nerve paresis (in parotid surgery)","volume":"35","author":"Zernial","year":"2007","journal-title":"J Cranio-maxillo-facial Surg"},{"issue":"9","key":"10.1016\/j.nmd.2020.09.029_bib0014","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1017\/S0022215113001801","article-title":"Prognostic factors for secondary recurrence of pleomorphic adenoma: a 20-year, retrospective study","volume":"127","author":"Malard","year":"2013","journal-title":"J Laryngol Otol"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bjoms.2018.01.021","article-title":"Current thinking about the management of recurrent pleomorphic adenoma of the parotid: a structured review","volume":"56","author":"Kanatas","year":"2018","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.nmd.2020.09.029_bib0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0404.1978.tb05876.x","article-title":"Coincidence of dystrophia myotonica and pleomorphic adenoma of the parotid gland","volume":"57","author":"Johannesson","year":"1978","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"10.1016\/j.nmd.2020.09.029_bib0017","first-page":"736","article-title":"[Somatic mosaicism of p(CTG)n expansion in a case of myotonic dystrophy with parotid tumor]","volume":"38","author":"Ogata","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"issue":"12","key":"10.1016\/j.nmd.2020.09.029_bib0018","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1258\/0022215001904563","article-title":"Pleomorphic adenoma and myotonic dystrophy: an association","volume":"114","author":"Draper","year":"2000","journal-title":"J Laryngol Otol"},{"issue":"10","key":"10.1016\/j.nmd.2020.09.029_bib0019","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nrg906","article-title":"Mechanisms and consequences of somatic mosaicism in humans","volume":"3","author":"Youssoufian","year":"2002","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/genes5041064","article-title":"Somatic mosaicism in the human genome","volume":"5","author":"Freed","year":"2014","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.nmd.2020.09.029_bib0021","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/humu.22757","article-title":"Germline & somatic mosaicism: the 2014 annual scientific meeting of the Human Genome Variation Society","volume":"36","author":"Oetting","year":"2015","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.nmd.2020.09.029_bib0022","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/s41593-018-0257-3","article-title":"Somatic mosaicism and neurodevelopmental disease","volume":"21","author":"D'Gama","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nmd.2020.09.029_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","article-title":"Genetics of Huntington disease","volume":"144","author":"Nance","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nmd.2020.09.029_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-016-0302-y","article-title":"Characteristics of gliomas in patients with somatic IDH mosaicism","volume":"4","author":"Bonnet","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.nmd.2020.09.029_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0303-6987.2005.00267.x","article-title":"Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin","volume":"32","author":"Lazar","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"15","key":"10.1016\/j.nmd.2020.09.029_bib0026","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.14.15.1837","article-title":"Wnt signaling and cancer","volume":"14","author":"Polakis","year":"2000","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.nmd.2020.09.029_bib0027","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.21400","article-title":"Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice","volume":"118","author":"Zhao","year":"2006","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.nmd.2020.09.029_bib0028","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0000000000003124","article-title":"Cancer risk in DM1 is sex-related and linked to miRNA-200\/141 downregulation","volume":"87","author":"Fern\u00e1ndez-Torr\u00f3n","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2020.09.029_bib0029","first-page":"1162","article-title":"MicroRNA-200a suppresses the Wnt\/\u03b2-catenin signaling pathway by interacting with \u03b2-catenin","volume":"40","author":"Su","year":"2012","journal-title":"Int J Oncol"},{"issue":"21","key":"10.1016\/j.nmd.2020.09.029_bib0030","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.00332-09","article-title":"Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway","volume":"29","author":"Saydam","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.nmd.2020.09.029_bib0031","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol Clin Pract"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:37Z","timestamp":1760775037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620306180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0960896620306180"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.09.029","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myotonic dystrophy and recurrent pleomorphic adenomas: Case report and association hypothesis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}